BioSpace News Archive

AIM ImmunoTech Inc., announced the next CEO Corner segment has been published on the Company’s website.

SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company, and M8 Pharmaceuticals, an Acino company (“M8”) are collaborating to bring an important drug for cancer patients to Latin America.

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, May 1, 2024.

Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Administration (FDA) has approved TRYVIO™ (aprocitentan) for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs.

Koneksa announced that Merck has joined its Data Syndication Partnership program for the LEARNS observational study, which seeks to develop digital biomarkers in neurodegenerative disorders from smart phone-based assessments and wearable technologies.

Elegen Launches ENFINIA ™ DNA Enhancement for Rapid Synthesis of Highly Complex DNA.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Friday, March 22, 2024.

Femasys Inc. today announces topline data from its FemaSeed Localized Directional Insemination for artificial insemination pivotal trial (NCT04968847).

We are thrilled to announce that Sitero’s IRB has received full accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Delcath Systems, Inc. confirmed the closing of the previously announced private placement with certain accredited investors comprised of existing investors.